Correlation between fibronectin and cardiothoracic ratio in heart failure treated with angiotensin converting enzyme inhibitors.
A group of 17 patients with ischemic heart disease, significant left ventricular dilatation and congestive heart failure, class III NYHA (9 patients) and class IV NYHA (8 patients) was studied. The patients received angiotensin converting enzyme inhibitor--captopril 75 mg/day or perindopril 4 mg/day--added to diuretics, digitalis and nitrates. The plasmatic level of fibronectin was investigated, by radial immunodiffusion, before and one month after the beginning of the treatment with angiotensin converting enzyme (ACE) inhibitor. The plasmatic level of fibronectin is increased significantly (p < 0.001) while the cardiothoracic ratio is decreased significantly (p < 0.02) after one month of ACE inhibitors treatment. A positive correlation between the increase of the plasmatic level of fibronectin and the decrease of cardiothoracic ratio is found (r = 0.62; p < 0.01). The increased fibronectin plasmatic level can be a marker of the favorable effect of ACE inhibitor on the myocardium interstitium.
Olinic
N
N
Medical Clinic no. 1, Cluj-Napoca, Romania.
Vida-Simiti
L
L
Cristea
A
A
Mureşan
A
A
Pop
S
S
Teşanu
E
E
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005353:Fibronectins / Q000097:blood* / Q000187:drug effects; D006333:Heart Failure / Q000097:blood* / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000097:blood* / Q000188:drug therapy* / Q000209:etiology; D017202:Myocardial Ischemia / Q000097:blood / Q000150:complications / Q000188:drug therapy; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D005353:Fibronectins